MedPath

The Safety, Acceptability and Efficacy of Alena

Not Applicable
Completed
Conditions
Social Anxiety Disorder (Social Phobia)
Social Anxiety
Social Anxiety Disorder
Interventions
Behavioral: Cognitive Behavioral Therapy programme
Registration Number
NCT05858294
Lead Sponsor
Aya Technologies Limited
Brief Summary

The present study is a randomised controlled trial that seeks to investigate the safety, acceptability and efficacy and safety of the Alena CBT programme as a treatment for social anxiety disorder.

Detailed Description

This is a 6-week web-based parallel-group unblinded randomised controlled trial with a 4-week intervention period and a 2-week follow-up post intervention. Participants are randomly allocated to receive access to the Alena CBT programme or to a wait list control group, in a 1:1 ratio. The programme consists of CBT-based therapy for social anxiety based on the Clark and Wells model.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
102
Inclusion Criteria
  • female
  • aged between 18 and 35 years old (inclusive)
  • located in the UK
  • fluent in English
  • comfortable taking part in a study that included deception (due to the nature of the cognitive assessments)
  • had an iPhone and daily access to an internet connection
  • scored over 30 on the Social Phobia Inventory (SPIN; indicating at least moderate social anxiety).
Exclusion Criteria
  • currently undergoing any mental health therapy
  • changed the usual mental health medication or dosage within the past eight weeks
  • scored eight or above on the Alcohol Use Disorders Identification Test for consumption (AUDIT-C; indicating higher risk of alcohol dependence)
  • scored two or above on the adapted drug questions (indicating higher risk of drug dependence)
  • had previously participated in scientific studies or user research undertaken by Alena

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cognitive Behavioral Therapy programCognitive Behavioral Therapy programmeAccess to the "Alena" CBT-based therapy programme for 4 weeks. Each of the four therapy modules gradually became available on a weekly basis until all four were available in the final intervention week. Participants were instructed to complete one module per week. Each therapy module consisted of psychoeducational content, guided psychological reflection and perspective-taking exercises, and, where appropriate, skills training exercises such as attention training, public speaking, and exposure experiments to be completed in real life.
Primary Outcome Measures
NameTimeMethod
Questionnaire assessing satisfaction, helpfulness and ease of useWeek 6 (2-week follow-up post-intervention)

Participants were asked how satisfied they were with the app overall (Likert rating scale from very dissatisfied to very satisfied); how helpful they found the app (Likert ratings from very unhelpful to very helpful); how likely they would be to recommend the app (Likert ratings from very unlikely to very likely); how easy they found using the app (Likert ratings from very difficult to very easy); whether they got to the end of the weekly exercise (yes/no), and what got in the way of completing the exercises, with options provided.

Questionnaires assessing negative effects from using the app and adverse health eventsWeek 6 (2-week follow-up post-intervention)

The Intervention group was asked "Have you experienced any negative effects from using the Alena app? This could be a physical or emotional effect that you believe you have experienced as a result of using the app and/or engaging in the app therapy." Both groups were asked: "Have you experienced any new, serious negative health effects in the past week? This includes having to see your GP for a new reason, going to hospital, or being otherwise very unwell in terms of your physical or mental health." If participants responded positively to either question, they were prompted for additional details and to rate the severity of the experience.

Secondary Outcome Measures
NameTimeMethod
Work and Social Adjustment Scale (WSAS)Week 6 (2-week follow-up post-intervention)

The WSAS measures the extent to which the respondent's problem impairs their ability to carry out day-to-day activities, such as work, home management and social leisure activities. Total score ranging from 0 to 40, with higher scores indicating higher impairment

Social phobia inventory (SPIN)Week 6 (2-week follow-up post-intervention)

The SPIN was designed to assess the full spectrum of symptoms that characterise social anxiety, including fear, avoidance and physiological components. Total score ranging from 0 to 68, with higher scores indicating a worse outcome.

Trial Locations

Locations (1)

Aya Technologies Limited

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath